Purinergic receptors and atherosclerosis: emerging role for vessel wall P2Y12

Cardiovasc Res. 2014 Jun 1;102(3):339-41. doi: 10.1093/cvr/cvu108. Epub 2014 Apr 22.

Authors

Bernhard H Rauch¹, János G Filep²

Affiliations

¹ Centre of Drug Absorption and Transport, Institute of Pharmacology, University Medicine Greifswald, Greifswald 17487, Germany bernhard.rauch@uni-greifswald.de janos.g.filep@umontreal.ca.
² Department of Pathology and Cell Biology, University of Montreal, and Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada H1T 2M4 bernhard.rauch@uni-greifswald.de janos.g.filep@umontreal.ca.

PMID: 24760550
DOI: 10.1093/cvr/cvu108

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Apolipoproteins E / physiology
Atherosclerosis / etiology*
Blood Platelets / physiology
Blood Vessels / physiology*
Humans
Receptors, Purinergic P2Y12 / physiology*

Substances

Apolipoproteins E
Receptors, Purinergic P2Y12